Xuan Liu
Xuan Liu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Shujuan Hu
School of Education and Physical Education, Yangtze University, Jingzhou 434023, China
2 shared publications - Xianwang Wang
Department of Biochemistry and Molecular Biology, Center for Molecular Medicine, Health Science Center, Yangtze University, Jingzhou 434023, China
2 shared publications - Dandan Jing
School of Education and Physical Education, Yangtze University, Jingzhou 434023, China
1 shared publication - Ruohan Xia
Health Science Center, Yangtze University, Jingzhou, China
1 shared publication - Xinxin Liu
School of Education and Physical Education, Yangtze University, Jingzhou 434023, China
1 shared publication
Latest Publications
- Open Access
- 12 October 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 766
Exercise-Associated Gut Microbiota Remodeling and Cardiovascular Protection: Potential Mechanisms Involving Inflammatory Regulation
Cardiovascular disease (CVD) remains a major contributor to global mortality and disease burden and encompasses a range of conditions commonly associated with metabolic disturbances, endothelial dysfunction, and chronic inflammation. Emerging evidence suggests that persistent low-grade inflammation contributes to the development and progression of CVD and represents an important component of its pathophysiology. The gut microbiota (GM) and microbiota-related metabolites are increasingly recognized as important regulators of host metabolism and immune homeostasis. GM dysbiosis may influence cardiovascular inflammation through alterations in microbial metabolites, intestinal barrier function, and inflammatory signaling, including the TLR4/NF-κB/NLRP3 pathway and immunoregulatory mechanisms involving IL-10 and context-dependent TGF-β signaling. Accumulating experimental and clinical evidence suggests that exercise may reshape GM composition and microbial metabolic profiles and may be associated with changes in inflammatory and immunoregulatory responses relevant to cardiovascular health. Evidence from atherosclerosis, hypertension, myocardial infarction, and myocardial ischemia–reperfusion injury further supports disease-specific associations among exercise, GM alterations, inflammatory signaling, and cardiovascular outcomes. Therefore, this review synthesizes current mechanistic, animal, and human evidence on these interconnected processes, with particular emphasis on the TLR4/NF-κB/NLRP3 and IL-10/TGF-β-related signaling pathways. Overall, current evidence supports disease-specific associations and potential mechanistic links among exercise, GM alterations, microbial metabolites, inflammatory regulation, and cardiovascular outcomes; however, the GM has not yet been established as a universal or causal mediator of exercise-related cardiovascular protection.
- 12 October 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 766
Open AccessExercise-Associated Gut Microbiota Remodeling and Cardiovascular Protection: Potential Mechanisms Involving Inflammatory Regulation
Cardiovascular disease (CVD) remains a major contributor to global mortality and disease burden and encompasses a range of conditions commonly associated with metabolic disturbances, endothelial dysfunction, and chronic inflammation. Emerging evidence suggests that persistent low-grade inflammation contributes to the development and progression of CVD and represents an important component of its pathophysiology. The gut microbiota (GM) and microbiota-related metabolites are increasingly recognized as important regulators of host metabolism and immune homeostasis. GM dysbiosis may influence cardiovascular inflammation through alterations in microbial metabolites, intestinal barrier function, and inflammatory signaling, including the TLR4/NF-κB/NLRP3 pathway and immunoregulatory mechanisms involving IL-10 and context-dependent TGF-β signaling. Accumulating experimental and clinical evidence suggests that exercise may reshape GM composition and microbial metabolic profiles and may be associated with changes in inflammatory and immunoregulatory responses relevant to cardiovascular health. Evidence from atherosclerosis, hypertension, myocardial infarction, and myocardial ischemia–reperfusion injury further supports disease-specific associations among exercise, GM alterations, inflammatory signaling, and cardiovascular outcomes. Therefore, this review synthesizes current mechanistic, animal, and human evidence on these interconnected processes, with particular emphasis on the TLR4/NF-κB/NLRP3 and IL-10/TGF-β-related signaling pathways. Overall, current evidence supports disease-specific associations and potential mechanistic links among exercise, GM alterations, microbial metabolites, inflammatory regulation, and cardiovascular outcomes; however, the GM has not yet been established as a universal or causal mediator of exercise-related cardiovascular protection.
- Open Access
Exercise Is Associated with Skeletal Muscle Autophagy–Lysosome-Related Markers and Nrf2/ARF1 Signaling in HFD Mice
Purpose: This study aimed to investigate the protective effects and potential mechanisms of exercise against long-term high-fat diet (HFD)-induced skeletal muscle dysfunction, with a focus on ADP-ribosylation factor 1 (ARF1)-related autophagy–lysosome markers and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling. Methods: Forty male C57BL/6 mice were randomly divided into a normal diet group (DC) and an HFD group, and the latter was further subdivided into a model group (MG), exercise group (EG), Nrf2 inhibitor group (NG), and exercise combined with Nrf2 inhibitor group (ENG) after 12 weeks of HFD feeding. EG received 6 weeks of moderate-intensity treadmill exercise, NG was treated with Nrf2 inhibitor for 6 weeks, and ENG received both the 6-week treadmill exercise and inhibitor injections simultaneously. Serum lipid, blood glucose and insulin resistance indices were detected; skeletal muscle morphology was observed by H&E staining; mRNA and protein expression of ARF1, ULK1, ATP6V0A1 and other factors were determined by RT-qPCR, Western blotting and immunohistochemistry; the oxidative stress index was measured by an ELISA; and the colocalization of ARF1/ATP6V0A1 with the lysosomal marker Lamp1 was analyzed by immunofluorescence. Results: Long-term HFD significantly increased mouse body weight, serum TC, TG, LDL-C, FBG levels and the HOMA-IR index, induced morphological alterations in skeletal muscle (loose myofiber arrangement, abundant intracellular vacuoles), inhibited the mRNA expression of ARF1, ULK1 and ATP6V0A1, and elevated malondialdehyde (MDA) content (p < 0.05 or p < 0.01). Six weeks of moderate-intensity treadmill exercise effectively improved HFD-induced metabolic disorders and skeletal muscle morphological damage, upregulated the expression of ARF1, ULK1 and ATP6V0A1, and reduced oxidative stress (p < 0.05 or p < 0.01). Notably, luteolin-mediated inhibition of Nrf2 signaling may partially reverse exercise-induced alterations in ARF1-related autophagy–lysosome markers and skeletal muscle morphology. Conclusions: Long-term HFD may induce morphological alterations in skeletal muscle, accompanied by changes in ARF1-associated autophagy–lysosome markers and elevated oxidative stress. Conversely, moderate-intensity exercise may ameliorate HFD-related changes in skeletal muscle morphology, potentially via Nrf2 signaling, providing a potential molecular target and theoretical basis for the exercise intervention strategies against HFD-induced metabolic-related skeletal muscle dysfunction.
Open AccessExercise Is Associated with Skeletal Muscle Autophagy–Lysosome-Related Markers and Nrf2/ARF1 Signaling in HFD Mice
Purpose: This study aimed to investigate the protective effects and potential mechanisms of exercise against long-term high-fat diet (HFD)-induced skeletal muscle dysfunction, with a focus on ADP-ribosylation factor 1 (ARF1)-related autophagy–lysosome markers and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling. Methods: Forty male C57BL/6 mice were randomly divided into a normal diet group (DC) and an HFD group, and the latter was further subdivided into a model group (MG), exercise group (EG), Nrf2 inhibitor group (NG), and exercise combined with Nrf2 inhibitor group (ENG) after 12 weeks of HFD feeding. EG received 6 weeks of moderate-intensity treadmill exercise, NG was treated with Nrf2 inhibitor for 6 weeks, and ENG received both the 6-week treadmill exercise and inhibitor injections simultaneously. Serum lipid, blood glucose and insulin resistance indices were detected; skeletal muscle morphology was observed by H&E staining; mRNA and protein expression of ARF1, ULK1, ATP6V0A1 and other factors were determined by RT-qPCR, Western blotting and immunohistochemistry; the oxidative stress index was measured by an ELISA; and the colocalization of ARF1/ATP6V0A1 with the lysosomal marker Lamp1 was analyzed by immunofluorescence. Results: Long-term HFD significantly increased mouse body weight, serum TC, TG, LDL-C, FBG levels and the HOMA-IR index, induced morphological alterations in skeletal muscle (loose myofiber arrangement, abundant intracellular vacuoles), inhibited the mRNA expression of ARF1, ULK1 and ATP6V0A1, and elevated malondialdehyde (MDA) content (p < 0.05 or p < 0.01). Six weeks of moderate-intensity treadmill exercise effectively improved HFD-induced metabolic disorders and skeletal muscle morphological damage, upregulated the expression of ARF1, ULK1 and ATP6V0A1, and reduced oxidative stress (p < 0.05 or p < 0.01). Notably, luteolin-mediated inhibition of Nrf2 signaling may partially reverse exercise-induced alterations in ARF1-related autophagy–lysosome markers and skeletal muscle morphology. Conclusions: Long-term HFD may induce morphological alterations in skeletal muscle, accompanied by changes in ARF1-associated autophagy–lysosome markers and elevated oxidative stress. Conversely, moderate-intensity exercise may ameliorate HFD-related changes in skeletal muscle morphology, potentially via Nrf2 signaling, providing a potential molecular target and theoretical basis for the exercise intervention strategies against HFD-induced metabolic-related skeletal muscle dysfunction.